Konvent Der Barmherzigen Brueder

At Konvent Der Barmherzigen Brueder in Linz, a major part of the clinical research portfolio focuses on cardiovascular diseases and metabolic disorders, including atherosclerotic cardiovascular disease, hypertension, type 2 diabetes, obesity, and severe hypertriglyceridemia. These studies are designed to test new ways to reduce heart-related events, improve risk-factor control, and support better long-term prevention.

• Testing therapies aimed at lowering major cardiovascular event risk
• Studying treatments for elevated lipoprotein(a) and familial cholesterol disorders
• Evaluating approaches to improve outcomes in diabetes, obesity, and kidney-related cardiovascular risk

This area reflects a strong interest in prevention and treatment strategies that may help reduce serious complications in people with high cardiometabolic risk.

The site’s Neurology department is active in trials for multiple sclerosis, migraine, stroke, and spasticity. Research in this field is centered on improving symptom control, preventing recurrent events, and assessing the safety and effectiveness of new or established treatments for neurological conditions.

• Evaluating medicines for migraine prevention and symptom relief
• Studying stroke prevention after ischemic stroke or transient ischemic attack
• Assessing longer-term treatment options for multiple sclerosis and post-stroke spasticity

These trials show a broad commitment to both chronic neurological disease management and recovery-focused care.

Clinical trials at the site also address eye diseases, especially age-related macular degeneration, macular edema, and myopia. The research aims to slow vision loss, improve visual function, and explore new treatment options for common retinal and refractive conditions.

• Investigating therapies for retinal swelling and degenerative retinal disease
• Testing approaches to slow myopia progression in children
• Assessing safety and vision outcomes of emerging eye treatments

This field is especially relevant for patients seeking better control of progressive vision problems and for clinicians looking for improved eye care options.

The research portfolio includes studies in neoplasms and hematologic diseases, with trials involving multiple myeloma, colorectal cancer, gastric and gastroesophageal junction cancer, pancreatic cancer, ovarian cancer, and HPV-associated cancers. These trials are focused on improving survival, extending disease control, and refining treatment strategies for both solid tumors and blood cancers.

• Testing new combinations for multiple myeloma and infection prevention during treatment
• Evaluating treatment effectiveness in advanced gastrointestinal and gynecologic cancers
• Studying targeted and immune-based approaches for cancer care

The site contributes to oncology research that seeks better outcomes for patients with difficult-to-treat or recurrent cancers.

Beyond its core neurology focus, the site supports trials in digestive system diseases, immune system diseases, musculoskeletal disorders, urogenital conditions, and virus diseases. Areas of interest include ulcerative colitis, radiation proctitis, and immune-related infection prevention, alongside studies in metabolic health and inflammatory conditions.

• Improving bowel symptoms and quality of life in ulcerative colitis and proctitis
• Evaluating infection prevention in people with weakened immune function
• Exploring treatment support for metabolic and inflammatory complications across several disease areas

This diverse activity highlights a broad clinical research environment with links between internal medicine, immune care, and symptom management.